Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00410371 · ClinicalTrials.gov registry record · Phase 1
Study to Compare Two Formulations of Lamotrigine in Healthy Subjects
A Phase 1 study of Mental Disorders, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT00410371 is a Phase 1 study of Mental Disorders that has completed, run by GlaxoSmithKline. The registered enrollment target is 96 participants, below the 681-participant average among 25 other Mental Disorders trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00410371, a Phase 1 study of Mental Disorders, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
This study intends to compare the pharmacokinetic characteristics, safety and tolerability of two formulations of lamotrigine in healthy male and female volunteers
Conditions Studied
Interventions
- DRUG Lamotrigine
- DRUG GI267119
Study Locations (1)
Nebraska
- GSK Investigational Site - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2006-12-28 |
| Est. Completion | 2007-01-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00410371
The ClinicalTrials.gov registry entry for NCT00410371 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 681-participant average among 25 other Mental Disorders trials with a reported enrollment target (86% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mental Disorders appearing as the primary indexed condition, and to 2 interventions - of which Lamotrigine is the first listed.
NCT00410371 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT00410371 about?
NCT00410371 is a clinical study titled "Study to Compare Two Formulations of Lamotrigine in Healthy Subjects". This study intends to compare the pharmacokinetic characteristics, safety and tolerability of two formulations of lamotrigine in healthy male and female volunteers
What is the current status of trial NCT00410371?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 96 participants. The study started on 2006-12-28. Estimated completion is 2007-01-25.
What conditions does trial NCT00410371 study?
This clinical trial studies the following conditions: Mental Disorders.
What interventions are being tested in trial NCT00410371?
The interventions under investigation include: Lamotrigine (DRUG), GI267119 (DRUG).
Who is sponsoring clinical trial NCT00410371?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00410371 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Relative Bioavailability of LY03010 Compared to Listed Drug
COMPLETED · Phase 1
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
RECRUITING · NA
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Stimulation-Induced Changes in Fronto-Limbic Network
RECRUITING · NA
-
Studying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.